Concepedia

Publication | Closed Access

A Randomized Multicenter Comparison of Basiliximab and Muromonab (OKT3) in Heart Transplantation: SIMCOR Study

DOI

62

Citations

19

References

2006

Year

Javier Segovia, Jos L. Rodr guez-Lambert, María G. Crespo‐Leiro, Luís Almenar, E. Roig, Miguel A. G mez-S nchez, E. Lage, Nicolás Manito, Luis Alonso-Pulp n
Transplantation

Abstract

In this HTx study, induction therapy with BAS was safer and better tolerated than OKT3, without significant differences in efficacy outcomes.

References

YearCitations

Page 1